Product ID: SQMIG35H2059
Global Bioinformatics Market Size, Share, Growth Analysis, By Products And Services(Knowledge Management Tools, Bioinformatics Platform (Sequence Analysis Platform), By Application(Microbial Genome, Gene Engineering) - Industry Forecast 2024-2031
Report ID:
SQMIG35H2059 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
75 |
Figures:
75
Global Bioinformatics Market Dynamics
Bioinformatics Market Driver
Growing Demand for Protein Sequencing for Research Initiatives to Empower
- Increasing demand for protein sequencing and nucleic acid along with initiatives from government and private organizations is bolstering the demand for bioinformatics in the global market. The market is further driven by increased research on drug delivery and molecular biology accompanied by growth in genomics and proteomics. Demand for computational epigenetics, a meta-analysis of microarray data, differentially expressed genes, gene networks, systems biology requirements, and gene-associating studies, among other things, have had a significant impact on the growth of the bioinformatics market.
- The introduction of technologically advanced bioinformatics software such as BALL, Bioclipse, RasMol, and AUTODOCK, the use of these tools relay effective and accurate analysis of biomarkers discovery programs that aid in toxicity detection during the early stages of the drug development process, are expected to drive industry growth in the coming years.
Bioinformatics Market Restraint
Need for Complex Systems to Handle Bioinformatics
- With the introduction of advanced NGS technologies, there is a growing demand for quick and accurate bioinformatics tools that are simple to use. The majority of experimental researchers are not bioinformaticians. As a result, the availability of user-friendly tools is critical for using bioinformatics platforms. Many bioinformatics tools necessitate advanced computer skills owing to the lack of a suitable user interface.
- Genomics instruments are also outfitted with advanced features and functionalities, and as a result, they are priced at a premium, ranging from USD 10–20 million. Because pharmaceutical companies and research laboratories require a large number of such systems, the capital investment in acquiring multiple genomic instruments is substantial. Small and medium-sized pharmaceutical companies and research laboratories cannot afford to make such large investments in multiple genomics instruments.
Global Bioinformatics Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
